- Home
- ALRM vs VRDN Comparison
ALRM vs VRDN Comparison
Compare ALRM & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALRM | VRDN |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALRM | VRDN |
|---|---|---|
| Price | $45.72 | $27.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $57.00 | $41.42 |
| AVG Volume (30 Days) | 385.3K | ★ 1.3M |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.42 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $1,011,187,000.00 | $5,706,000.00 |
| Revenue This Year | $5.03 | $26,080.80 |
| Revenue Next Year | $3.95 | $2.07 |
| P/E Ratio | $18.53 | ★ N/A |
| Revenue Growth | ★ 7.59 | N/A |
| 52 Week Low | $44.71 | $9.90 |
| 52 Week High | $61.40 | $34.29 |
Technical Indicators
Market Signals| Indicator | ALRM | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 31.53 |
| Support Level | $44.71 | $27.41 |
| Resistance Level | $46.86 | $29.03 |
| Average True Range (ATR) | 1.56 | 1.41 |
| MACD | -0.09 | -0.34 |
| Stochastic Oscillator | 18.09 | 5.02 |
Price Performance
Historical ComparisonAbout ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).